Paper of the Month - September, 2011

Synergistic effect of sorafenib and sunitinib with enzastaurin, a selective protein kinase C inhibitor in renal cell carcinoma cell lines.

Vogl UM, Berger W, Micksche M et al.


WEB LINKS

SUBMIT AN ARTICLE